The BIOSECURE Act: Assessing Its Impact on Biotechnology Partnerships with Chinese Firms
Bipartisan legislation advancing in the U.S. Senate and the U.S. House of Representatives known as the “BIOSECURE Act” (“the Act”) has the potential to restrict the ability of biotechnology companies to collaborate with certain Chinese companies without losing the ability to contract with the U.S. government. Following the same model that was used to target […]
The post The BIOSECURE Act: Potential Implications for Biotechnology Collaborations with Chinese Companies appeared first on Healthcare & Life Sciences Blog.
Read More